Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04255121
Other study ID # PO19144*
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date June 22, 2020
Est. completion date February 26, 2021

Study information

Verified date February 2021
Source CHU de Reims
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

During labor, pain is systematic. In France, epidural analgesia is the gold standard to fight pain. Sometimes, emergency situations involve the maternal or fetal prognosis and require an emergency fetal extraction by caesarean. When an effective epidural analgesia is in place, an injection of adrenaline lidocaine converts this epidural analgesia into an epidural anesthesia allowing a surgical procedure. Sometimes, the time required to set up the anesthesia cannot be expected and a general anesthesia is performed. Local anesthetics used during epidural analgesia have Pka between 7.8 and 8.1. In solution, local anesthetics exist in two forms: an un-ionized form and an ionized form. The non-ionized form is liposoluble and crosses the lipid membranes to reach the site of intracellular action. The non-ionized form conditions the time taken to install anesthesia. When the pH of the solution is equal to Pka, un-ionized and ionized form are present in equal quantity. Commercial local anesthetic solutions have acidic pH and so contained a majority of ionized form. Alkalinization of local anesthetics solution should bring the pH closer to pKa and therefore to favor a greater proportion of non-ionized form.


Description:

The aim of this study is to evaluate impact of an alkalinization of adrenaline lidocaine solution for conversion of epidural analgesia into epidural anesthesia during an emergency caesarean.


Recruitment information / eligibility

Status Completed
Enrollment 400
Est. completion date February 26, 2021
Est. primary completion date December 13, 2020
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - pregnant women followed up in the Reims University Hospital - women whose birth is expected by vaginal delivery in the Reims University Hospital - women wishing to benefit from epidural analgesia - women agreeing to participate in the research and having signed informed consent - women aged 18 years old and more - women affiliated to a social security system Exclusion Criteria: - women who don't benefit from emergency caesarian (vaginal delivery or scheduled caesarian) - women for whom epidural analgesia cannot be used - women for whom epidural analgesia is not effective

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
2% adrenaline lidocaine associated with 4.2% sodium bicarbonate
conversion of epidural analgesia into epidural anesthesia during an emergency caesarean using an alkalinization of adrenaline lidocaine solution
2% adrenaline lidocaine
conversion of epidural analgesia into epidural anesthesia during an emergency caesarean using an adrenaline lidocaine solution

Locations

Country Name City State
France Chu Reims Reims

Sponsors (1)

Lead Sponsor Collaborator
CHU de Reims

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary delay in obtaining a T6 anesthetic level delay to obtain a T6 anesthetic level evaluated in minute 15 minutes